Switching from Biphasic Human Insulin to Premix Insulin Analogs: A Review of the Evidence Regarding Quality of Life and Adherence to Medication in Type 2 Diabetes Mellitus.

about

Switching from Biphasic Human Insulin to Premix Insulin Analogs: A Review of the Evidence Regarding Quality of Life and Adherence to Medication in Type 2 Diabetes Mellitus.

Item

http://www.wikidata.org/entity/Q38980053

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Switching from Biphasic Human ...... n in Type 2 Diabetes Mellitus.

@en

type

Item

label

Switching from Biphasic Human ...... n in Type 2 Diabetes Mellitus.

@en

prefLabel

Switching from Biphasic Human ...... n in Type 2 Diabetes Mellitus.

@en

P1476

Switching from Biphasic Human ...... n in Type 2 Diabetes Mellitus.

@en

P2093

Nabil El Naggar

http://www.w3.org/2001/XMLSchema#string

Sanjay Kalra

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

EuroQol--a new facility for the measurement of health-related quality of life

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Flexibility in insulin prescription

Insulin analogs--is there a compelling case to use them? No!

Quality of life and diabetes.

Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors.

Effects of twice-daily injections of premixed insulin analog on glycemic control in type 2 diabetic patients

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin.

Clinical safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: results from the Indonesian cohort of the A₁chieve study.

P2888

s12325-016-0418-2

P304

2091-2109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-016-0418-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003419191

http://www.w3.org/2001/XMLSchema#string

P698

27739002

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

type-2 diabetes